Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-26 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C251-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-757 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-753 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-44 |
filingDate |
2000-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2001-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9872a3b37cd84cf3cafb30b594649de6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_274bc7998c2c4d4a47281330ac13f10f |
publicationDate |
2001-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6175034-B1 |
titleOfInvention |
Anti-viral compounds |
abstract |
The present invention provides compounds which inhibit an envelope virus by inhibiting the fusion of the virus with the host cell. The virus may be inhibited in an infected cell, a cell susceptible of infection or a mammal in need thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7312031-B1 |
priorityDate |
2000-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |